Ticks Archives - PharmaLive

U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac

Adults, Biologics License Application (BLA), Brain, Children, FDA, PDUFA, Pfizer, Priority Review Status, Spine, Tick-Borne Encephalitis (TBE), Ticks, Viral Infections

The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company’s tick-borne encephalitis vaccine for active immunization to prevent TBE in individuals 1 year of age and older.

February 23, 2021/by Andrew Humphreys

New Tickborne Infection, More Common Than Once Believed, Circulating In Northeastern U.S.

Anaplasmosis, Annals of Internal Medicine, Babesiosis, Borrelia Miyamotoi Disease (BMD), DNA, Health, Hospitalizations, Lyme Disease, Polymerase Chain Reaction (PCR), Tick-Borne Diseases, Ticks

While most of us are concerned about Lyme disease, a tickborne illness circulating during the spring and summertime in the Northeastern U.S, there is another, potentially more serious infection […]

June 8, 2015/by Forbes Health